Navigation Links
AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
Date:1/24/2008

CARLSBAD, Calif., Jan. 24 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions announced today that it has obtained clearance from the Food and Drug Administration (FDA) for its INFINITI 2C9-VKORC1 Multiplex Assay for Warfarin. The company has already received FDA clearance for its INFINITI Analyzer and FII/FV assays in 2007.

"We are excited to receive FDA clearance for our warfarin test," said Fareed Kureshy, President and CEO of AutoGenomics. "The FDA recently re- labeled warfarin stating that genetic testing may help optimize the use of the drug and lower the risk of bleeding complications. Several of our customers are awaiting such clearance to implement testing in their practice. We continue to expand our product portfolio with additional warfarin assays and are committed to be the lead player in this testing arena."

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. http://www.autogenomics.com


'/>"/>
SOURCE AutoGenomics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
2. ImmunoVaccine Technologies Receives $3 Million From ACOA
3. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
4. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
5. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
6. Novadaqs SPY System receives clearance for use in organ transplant surgery
7. BeneChills RhinoChill System Receives CE Marking for European Commercial Sale
8. e-Health Card Terminal From SCM Microsystems Receives GEMATIK Certification
9. Breckenridge Pharmaceutical Settles Paragraph IV Litigation and Receives FDA Approval for its Oxcarbazepine ANDA
10. LifeMasters Receives Full URAC Disease Management Accreditation
11. Federal Government Receives Failing Grades on Tobacco Control in Annual American Lung Association Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: a ... “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, a retired ... collections. , “I have been writing since high school and have many different ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... an On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician ... on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The ...
(Date:1/19/2017)... Beach, Florida (PRWEB) , ... January 19, 2017 , ... ... J.D., LCSW, announced that the name of their drug rehab center in Delray Beach, ... time we recognize that not only stars such as Philip Seymour Hoffman and Chris ...
(Date:1/19/2017)... ... ... Cosmetic Town, an online plastic surgery community, begins 2017 with an update ... their readers to get the information they desire. The procedures are now listed according ... on those particular areas. , “We are excited to streamline our listings in a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Report Details ... Alzheimer,s Disease ... Companies – our new study reveals trends, R&D progress, ... events affecting the Alzheimer,s disease therapeutics and diagnostics market. ... key questions: - How is the Alzheimer,s disease therapeutics ...
(Date:1/19/2017)... , Jan. 19, 2017 Many patients don,t ... their medication when a pharmacy just a few blocks ...  To alleviate this problem Medicationdiscountcard.com has created ... see exactly how much their medication will cost at ... Easy Medicationdiscountcard.com takes ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
Breaking Medicine Technology: